Gregory Gubitz
Chief Executive Officer at Grosvenor Ventures Ltd.
Net worth: 172 500 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Deborah Rathjen | M | - | 7 years | |
| Ryan Lennox | M | 43 | 6 years | |
| Peter van der Velden | M | 62 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | 19 years |
| John Hanna | M | - | 1 years | |
| John Welborn | M | 46 | 3 years | |
| Thomas Jefferd | M | - |
HydRx Farms Ltd.
 HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | 10 years |
| Rodney Hill | M | 56 | 6 years | |
| Kyle Dempsey | M | 35 | 2 years | |
| Norma Beauchamp | F | 62 | 3 years | |
| Harpreet Grover | M | - |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | - |
| Jason Gross | M | 59 |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | 10 years |
| Craig Millian | M | 56 | 1 years | |
| Daniel Hetu | M | - |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | 19 years |
| Laura Brege | F | 66 | 5 years | |
| David Spence | M | 56 | 6 years | |
| Domenic Serafino | M | 64 |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | - |
| Derek Riley | M | - |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | - |
| Bruce G. Cousins | M | 63 |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | - |
| Michael S. Cloutier | M | - |
HydRx Farms Ltd.
HydRx Farms Ltd. Agricultural Commodities/MillingProcess Industries HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada. | - |
| Patricia Perry | F | 48 | 5 years | |
| Brian Walsh | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gilbert Godin | M | 65 |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 10 years |
| William McDowall Wells | M | 63 |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 14 years |
| Donald Olds | M | 64 | 2 years | |
| Wolfgang Blättchen | M | 71 |
McGill University
| 9 years |
| Michael Mueller | M | 64 |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | 2 years |
| Michael Berendt | M | 75 | 3 years | |
| J. Lanthier | M | 83 |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 11 years |
| Mark Day | M | 52 | 2 years | |
| Jennifer Shea | F | - | 10 years | |
| David J. Clark | M | 68 | 8 years | |
| Yvon Bastien | M | 77 | - | |
| Beena Goldenberg | F | 61 |
McGill University
| 5 years |
| Walter di Bartolomeo | M | - |
McGill University
| 6 years |
| H. Christian Fibiger | M | 80 | 7 years | |
| Marc Lemieux | M | - |
McGill University
| 8 years |
| Patrick C. Lincoln | M | - |
McGill University
| 8 years |
| Teck Cheong Ho | M | 65 |
McGill University
| 6 years |
| Jennifer Tindale | F | - |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 4 years |
| Daniel Tassé | M | 64 | 1 years | |
| Hermanth Varghese | M | 49 | 5 years | |
| Hosen S. Marjaee | M | - |
McGill University
| 5 years |
| Yoke Keong Yong | M | 64 |
McGill University
| 7 years |
| Vee Kachroo | M | - |
McGill University
| 13 years |
| Nancy E. Stagliano | M | 57 | 2 years | |
| Donald DeGolyer | M | 63 | 5 years | |
| Pierre Carabin | M | - |
McGill University
| 5 years |
| Mairi Phillips | F | - | 12 years | |
| Judith F. Dalling | F | 69 | 3 years | |
| Lyne Fortin | F | 64 | 3 years | |
| Nathan M. Stubina | M | 65 |
McGill University
| 6 years |
| Laurence Nicole Mengin de Loyer | F | 56 |
McGill University
| 4 years |
| Catherine London | F | - | - | |
| Mahalakshmi Radhakrishnan | M | - | 1 years | |
| Tim Hendrickson | M | 52 | 9 years | |
| Jean-Pierre Landry | M | - |
McGill University
| 4 years |
| Terry Pearson | M | 78 | 9 years | |
| Michel Léonard | M | 66 |
McGill University
| 7 years |
| Karoly Nikolich | M | - |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 4 years |
| Margaret Cunningham | M | - | 10 years | |
| Salvatore Ruscitti | M | - |
McGill University
| 8 years |
| Neil Wiener | M | - |
McGill University
| 7 years |
| Albert Beraldo | M | - | 3 years | |
| Stanley Alkemade | M | - | 14 years | |
| Peter Krogh Jensen | M | 72 |
McGill University
| 7 years |
| Jonathan Murray Diamond | M | 67 |
McGill University
| 6 years |
| Arthur Evrensel | M | 66 |
McGill University
| 8 years |
| Wendy A. Kelley | F | - |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 4 years |
| André Chabot | M | - |
McGill University
| 5 years |
| Lyle Vanclief | M | - | 8 years | |
| Christopher Theodoropoulos | M | 69 |
McGill University
| 4 years |
| Marc Olivier | M | - |
McGill University
| 3 years |
| David Seters | M | - |
McGill University
| 3 years |
| Robert Coallier | M | 63 |
McGill University
| 4 years |
| Daniel Dorey | M | 64 |
McGill University
| 2 years |
| Elliot Cooperstone | M | 62 |
McGill University
| 3 years |
| Richard Groome | M | 66 |
McGill University
| 2 years |
| David J. Leffell | M | - |
McGill University
| 4 years |
| Sophie Soelaiman | F | 63 |
McGill University
| 4 years |
| Philip Webster | M | - |
McGill University
| 6 years |
| Toufic I. Boubez | M | - |
McGill University
| 4 years |
| Brian Conway | M | - |
McGill University
| 4 years |
| Anne Martin-Vachon | F | 62 |
McGill University
| 2 years |
| Sharon Langshur | M | - |
McGill University
| 4 years |
| Andrew Gertler | M | 61 |
McGill University
| 4 years |
| Patrick Gagnon | M | 61 |
McGill University
| 4 years |
| Stephen William Kibsey | M | - |
McGill University
| 6 years |
| Peter Cashin | M | 68 |
McGill University
| 1 years |
| William R. Walker | M | - |
McGill University
| 4 years |
| Jeffrey Kelisky | M | - |
McGill University
| 5 years |
| Colin Osborne | M | 59 |
McGill University
| 4 years |
| Richard Duke | M | - |
McGill University
| 3 years |
| Hyman M. Schipper | M | - |
McGill University
| 3 years |
| Scott Jones | M | 68 |
McGill University
| 4 years |
| Pierre Leroux | M | - |
McGill University
| 4 years |
| Carmine de Somma | M | - |
McGill University
| 4 years |
| Peter G. Wilson | M | 61 |
McGill University
| 4 years |
| Clifford Minn Rhee | M | 56 |
McGill University
| 4 years |
| Claude Michaud | M | - |
McGill University
| 4 years |
| Natalie Piccinin | F | 59 |
McGill University
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 91 | 91.00% |
| United States | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gregory Gubitz
- Personal Network
